.png){kind=logo}
May 2025 features several SME IPOs worth watching, including Srigee DLM with a 34% expected gain and tech-driven Virtual Galaxy Infotech at 14%. Others like Manoj Jewellers, Integrity Infrabuild, and Accretion Pharmaceuticals show promise but lack clear projections. Investors should assess risks before committing to these offerings
May 2025 is shaping up to be an exciting month for investors, with several high-profile companies making their debut in the stock market. An Initial Public Offering (IPO) is when a company offers its shares to the public for the first time, helping it raise capital to grow, while giving investors a chance to own a piece of the business and potentially earn returns. Here's a look at the top IPOS to watch this month.
Price: ₹99
Expected Gain: 34%
Offer Dates: 5-7 May
Segment: BSE SME
The Srigee DLM IPO is getting a lot of attention. The shares are priced at ₹99, and investors expect a 34% gain. This company is part of the SME (Small and Medium Enterprises) sector, which can offer big rewards, but also comes with more risk. The strong demand for these shares suggests it could be a good investment.
Price: ₹142
Expected Gain: 14%
Offer Dates: 9-14 May
Segment: NSE SME
The Virtual Galaxy Infotech IPO is for a tech company. Shares are priced at ₹142, and investors are expecting a 14% gain. With the strong interest in technology, this IPO looks like a great option for anyone looking to invest in the tech world.
Price: ₹54
Expected Gain: Unknown
Offer Dates: 5-7 May
Segment: BSE SME
Manoj Jewellers is offering its shares at ₹54. There’s no clear idea yet about how much gain investors can expect from this IPO. Since the company works in jewellery, it might do well, but it’s hard to say for sure right now.
Price: ₹100
Expected Gain: Unknown
Offer Dates: 13-15 May
Segment: NSE SME
The Integrity Infrabuild Developers IPO is priced at ₹100. This company works in real estate, which can be a good investment in the long run. However, it’s hard to know right now how much investors can expect to make. It’s one to watch for anyone interested in property.
Price: ₹101
Expected Gain: Unknown
Offer Dates: 14-16 May
Segment: NSE SME
The Accretion Pharmaceuticals IPO is priced at ₹101. This company is in the healthcare industry. While the gain is unclear, pharmaceutical companies can be a good bet for the long term. Investors who like the health sector might want to check it out.
May 2025 presents some interesting IPOS. Srigee DLM and Virtual Galaxy Infotech appear to be the top choices with gains of 34% and 14% predicted. Wagons Learning and Manoj Jewellers are also contenders, although their gains are questionable. If real estate is your thing, Integrity Infrabuild Developers may be the way to go. For those who like healthcare, Accretion Pharmaceuticals is a possible consideration.
Before putting money into an IPO, it's smart to learn more about the company first. IPOs can help you make money, but they can also lead to losses. Always think about what you want from your investment and how much risk you are okay with.
